Antitumor Effect of Metformin in Combination with Binimetinib on Melanoma Cells

Cutaneous melanoma is a fatal disease for patients with distant metastasis. Metformin is the most widely used anti-diabetic drug, and proved to suppress cell proliferation and metastasis in diverse cancers including melanoma. We previously reported that MEK inhibitor trametinib increases the express...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eunsung, Kwon, Yongjae, Kim, Jiwon, Park, Deokbae, Lee, Youngki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Developmental Biology 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328479/
https://www.ncbi.nlm.nih.gov/pubmed/34386644
http://dx.doi.org/10.12717/DR.2021.25.2.93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328479/
https://www.ncbi.nlm.nih.gov/pubmed/34386644
http://dx.doi.org/10.12717/DR.2021.25.2.93

Ejemplares similares